The tumor xenograft model showed that overexpression of USP2-AS1 promoted the growth of tumor while USP2-AS1 knockdown inhibited the proliferation of HCC in vivo (Figures 6B–E). The gene discussed is USP2; the disease is hepatocellular carcinoma.